Gray Nancy Ryan 4
4 · LIGAND PHARMACEUTICALS INC · Filed May 17, 2024
Insider Transaction Report
Form 4
Gray Nancy Ryan
Director
Transactions
- Sale
Common Stock
2024-05-09$83.20/sh−934$77,713→ 5,633 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $83.1100 to $83.2650. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.